• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心脏药物中卡维地洛和氢氯噻嗪定量分析的绿色高效液相色谱策略,包括体外溶出动力学和杂质剖析。

Green HPLC strategy for quantification of carvedilol and hydrochlorothiazide in cardiac medications with in-vitro dissolution kinetics and impurity profiling.

作者信息

Nabil Mona, Ahmed Dina A, Abbas Samah S, Lotfy Hayam M, Marzouk Hoda M

机构信息

Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo, 11562, Egypt.

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Cairo, 11835, Egypt.

出版信息

BMC Chem. 2025 Jul 3;19(1):187. doi: 10.1186/s13065-025-01559-2.

DOI:10.1186/s13065-025-01559-2
PMID:40611289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12224793/
Abstract

The introduction of new pharmaceutical formulations necessitates the development of a trustworthy analytical approach capable of quantifying active ingredients in various quality control procedures. A fixed dosage combination of carvedilol (CAR) and hydrochlorothiazide (HCT) has been introduced to treat hypertension with potential recommendation for diabetic patients. Ahigh-performance liquid chromatographic methodology, designed to be ecologically sustainable while maintaining high precision and accuracy, was established. This approach can simultaneously determine both drugs in their pure forms, and dosage form, along with separation and quantification of potential hydrochlorothiazide related impurities; salamide (DSA) and chlorothiazide (CT). Successful separation was performed using YMCTriart-Phenyl analytical column via gradient elution employing 0.1% formic acid alongside ethanol at a flow rate of 1.0 mL/min, coupled with photodiode array detection at 254.0 nm. Linearity was obtained across the concentration ranges of 0.1 to 100.0 µg/mL for HCT and CAR and 0.05 to 10.0 µg/mL for DSA and CT. The suggested chromatographic methodology can estimate HCT and CAR in different real samples. Additionally, it facilitates the concurrent monitoring of their dissolution profiles. The studied method's performance was validated in adherence to the guidelines set by the International Conference on Harmonization (ICH). Moreover, its ecological sustainability as well as applicability profile was further affirmed via diverse greenness, blueness, and whiteness assessment tools and compared among official and other reported procedures. In addition, the recently introduced Carbon Footprint Reduction Index tool has been implemented to assess the suggested method with an emphasis on estimating CO emissions. In general, the suggested methodology proves to be effective for conducting the quality control examination of raw forms and commercially accessible preparations.

摘要

新药物制剂的引入需要开发一种可靠的分析方法,以便在各种质量控制程序中对活性成分进行定量分析。已引入卡维地洛(CAR)和氢氯噻嗪(HCT)的固定剂量组合来治疗高血压,并可能推荐给糖尿病患者。建立了一种高性能液相色谱方法,该方法在保持高精度和准确性的同时,设计为具有生态可持续性。该方法可以同时测定纯形式和剂型中的两种药物,以及潜在的氢氯噻嗪相关杂质;水杨酰胺(DSA)和氯噻嗪(CT)的分离和定量。使用YMCTriart-苯基分析柱通过梯度洗脱成功分离,流动相为0.1%甲酸与乙醇,流速为1.0 mL/min,并在254.0 nm处进行光电二极管阵列检测。HCT和CAR在0.1至100.0 µg/mL的浓度范围内呈线性,DSA和CT在0.05至10.0 µg/mL的浓度范围内呈线性。所建议的色谱方法可以估计不同实际样品中的HCT和CAR。此外,它有助于同时监测它们的溶出曲线。所研究方法的性能按照国际协调会议(ICH)制定的指南进行了验证。此外,通过各种绿色度、蓝色度和白色度评估工具进一步确认了其生态可持续性以及适用性,并与官方和其他报道的程序进行了比较。此外,最近引入的碳足迹减少指数工具已用于评估所建议的方法,重点是估计碳排放。总体而言,所建议的方法被证明对于进行原料药形式和商业可得制剂的质量控制检查是有效的。

相似文献

1
Green HPLC strategy for quantification of carvedilol and hydrochlorothiazide in cardiac medications with in-vitro dissolution kinetics and impurity profiling.用于心脏药物中卡维地洛和氢氯噻嗪定量分析的绿色高效液相色谱策略,包括体外溶出动力学和杂质剖析。
BMC Chem. 2025 Jul 3;19(1):187. doi: 10.1186/s13065-025-01559-2.
2
Facile Integration of Hanztsch's Switch-Off/On Modeled Fluorogenic Probe for Feasible Tagging and Tracking of the Midodrine Drug in Different Matrices; First Evaluation of the Method's Greenness, Whiteness, Blueness, Quantum Yield, and Tablets' Content Homogeneity.汉茨希开关关闭/开启型荧光探针的简便集成,用于在不同基质中对米多君药物进行可行的标记和追踪;该方法的绿色度、白度、蓝度、量子产率及片剂含量均匀性的首次评估
J Fluoresc. 2024 Aug 5. doi: 10.1007/s10895-024-03839-x.
3
A sustainable multi-task HPLC-UV method for simultaneous analysis of top neuromodulating agents in diverse pharmaceutical formulations.一种用于同时分析多种药物制剂中顶级神经调节药物的可持续多任务高效液相色谱-紫外检测方法。
Sci Rep. 2025 Jul 2;15(1):22724. doi: 10.1038/s41598-025-07502-8.
4
Eco-friendly QbD-optimized chromatographic method for simultaneous analysis of metronidazole and nicotinamide with applications in permeation, stability, and sustainability evaluation.用于同时分析甲硝唑和烟酰胺的环保型质量源于设计(QbD)优化色谱方法及其在渗透、稳定性和可持续性评估中的应用
BMC Chem. 2025 Jul 3;19(1):195. doi: 10.1186/s13065-025-01555-6.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
[Fast determination of per- and polyfluoroalkyl substances in human serum by cold-induced phase separation coupled with liquid chromatography-tandem mass spectrometry].[冷诱导相分离结合液相色谱-串联质谱法快速测定人血清中的全氟和多氟烷基物质]
Se Pu. 2025 Jul;43(7):756-766. doi: 10.3724/SP.J.1123.2024.11028.
7
Innovative Synchronous Spectrofluorometric Method for Assessing a Novel Drug Combination in Amyotrophic Lateral Sclerosis: In Vivo Human Application With Greenness and Sustainability Evaluation.用于评估肌萎缩侧索硬化症新型药物组合的创新同步荧光光谱法:绿色度和可持续性评估的体内人体应用
Luminescence. 2025 Jun;40(6):e70222. doi: 10.1002/bio.70222.
8
Green and sustainable LC-APCI-MS/MS method for simultaneous quantification of genotoxic nitrosamines in antidiabetic medication: sitagliptin.用于同时定量抗糖尿病药物西他列汀中基因毒性亚硝胺的绿色可持续液相色谱-大气压化学电离串联质谱法
BMC Chem. 2025 May 20;19(1):135. doi: 10.1186/s13065-025-01503-4.
9
[Preparation and chromatographic performance evaluation of hydrophilic interaction chromatography stationary phase based on amino acids].基于氨基酸的亲水作用色谱固定相的制备及色谱性能评价
Se Pu. 2025 Jul;43(7):734-743. doi: 10.3724/SP.J.1123.2025.04015.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Introducing the carbon footprint reduction index (CaFRI) as a software-supported tool for greener laboratories in chemical analysis.引入碳足迹减少指数(CaFRI)作为一种软件支持的工具,用于打造更绿色的化学分析实验室。
BMC Chem. 2025 May 9;19(1):121. doi: 10.1186/s13065-025-01486-2.
2
Risk assessment based on spectrophotometric signals used in eco-friendly analytical scenarios for estimation of carvedilol and hydrochlorothiazide in pharmaceutical formulation.基于分光光度信号的风险评估用于环保分析场景中,以估算药物制剂中的卡维地洛和氢氯噻嗪。
Sci Rep. 2024 Aug 23;14(1):19657. doi: 10.1038/s41598-024-69746-0.
3
Simultaneous Chromatographic Estimation of Vildagliptin and Dapagliflozin Using Hybrid Principles of White Analytical Chemistry and Analytical Quality by Design.
采用白分析化学和分析质量设计的混合原理同时测定维格列汀和达格列净。
J AOAC Int. 2024 Jan 4;107(1):212-222. doi: 10.1093/jaoacint/qsad108.
4
Implementation of White Analytical Chemistry-Assisted Analytical Quality by Design Approach to Green Liquid Chromatographic Method for Concomitant Analysis of Anti-Hypertensive Drugs in Human Plasma.采用白色分析化学辅助的设计分析质量方法实现绿色液相色谱法同时分析人血浆中的抗高血压药物
J Chromatogr Sci. 2024 Dec 11;62(10):938-952. doi: 10.1093/chromsci/bmad054.
5
Spectrophotometric platform windows' exploitation for the green determination of Alcaftadine in presence of its oxidative degradation product.分光光度平台窗口的开发用于在其氧化降解产物存在下绿色测定阿伐斯汀。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Sep 5;297:122737. doi: 10.1016/j.saa.2023.122737. Epub 2023 Apr 13.
6
Sustainable spectrophotometric determination of antihypertensive medicines reducing COVID-19 risk via paired wavelength data processing technique - Assessment of purity, greenness and whiteness.通过配对波长数据处理技术对降低COVID-19风险的抗高血压药物进行可持续分光光度法测定——纯度、绿色度和白度评估
Sustain Chem Pharm. 2022 Oct;29:100806. doi: 10.1016/j.scp.2022.100806. Epub 2022 Aug 15.
7
Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection.采用分光光度平台不同窗口的粘贴-拉拔策略评估联合药物治疗 COVID-19 大流行中棘手症状的管理-假冒伪劣产品检测。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Sep 5;277:121256. doi: 10.1016/j.saa.2022.121256. Epub 2022 Apr 20.
8
Fingerprinting and iso-absorptive resolution techniques for the spectrally overlapping Dutasteride and Silodosin mixture: Content uniformity testing along with greenness profile assessment.指纹图谱和等吸收分辨率技术用于光谱重叠的度他雄胺和西洛多辛混合物:含量均匀度检测以及绿色度评估。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 May 15;273:121063. doi: 10.1016/j.saa.2022.121063. Epub 2022 Feb 19.
9
A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling.一种用于测定法匹拉韦(一种用于治疗COVID-19的潜在抗病毒药物)的新型稳定性指示高效液相色谱-二极管阵列检测法;应用于降解动力学研究和体外溶出度分析。
Microchem J. 2022 Jan;172:106917. doi: 10.1016/j.microc.2021.106917. Epub 2021 Oct 15.
10
Evaluation of in silico and in lab sample enrichment techniques for the assessment of challengeable quaternary combination in critical ratio.评估用于临界比例中可挑战的四元组合评估的计算机模拟和实验室样本富集技术。
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Nov 5;260:119943. doi: 10.1016/j.saa.2021.119943. Epub 2021 May 11.